Aktualności
EMA: Concept paper on use of aminoglycosides in animals in the European Union: Development of resistance and impact on human and animal health
24.07.2014
Aminoglycosides have a broad antibacterial spectrum with good activity against Gram negative species and less activity against Gram positive species. This class of antimicrobials has no effect
...
EMA: Concept paper on transferring quality control methods validated in collaborative trials to a product/laboratory specific context
24.07.2014
Demonstration of scientific validity is a necessary condition for regulatory acceptance of any test method, including 3R (replacement, reduction, refinement) testing approaches. ...
GMP: Final ICH M7 Guideline on Genotoxic Impurities published
24.07.2014
On on 15 July 2014, the ICH issued the guideline M7 \"Assessment and Control of DNA reactive (mutagenic) Impurities in Pharmaceuticals to limit Potential Carcinogenic Risk\" as Step 4 document. In
...
EMA: Guide on methodological standards in pharmacoepidemiology revised to include pharmacogenetic studies
17.07.2014
The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP), coordinated by the European Medicines Agency, has revised its guide on methodological standards in
...
GMP: New GMP Non-Compliance Reports in EMA Database
17.07.2014
The European Medicines Agency (EMA) has established a database which contains GMP and GDP compliance information. This database is called EudraGMDP. ...
RAPS: FDA Revises Policies on Obtaining Informed Consent in Clinical Trials
17.07.2014
A new draft guidance document issued by the US Food and Drug Administration (FDA) is meant to eventually replace a 16-year-old guide outlining the regulator\'s views on informed consent. ...
GMP: India blocks further Expansion of the ICH Harmonisation
17.07.2014
India blocks the further expansion and therefore the success of the International Conference on Harmonisation (ICH). Together with some patient groups, the country wants to avoid that the World
...
EMA: Draft detailed guide regarding the monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency
10.07.2014
Scientific and medical literature is an important source of information on suspected adverse reaction case reports (also referred to as individual case safety reports). Currently, for active
...
EMA: European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
10.07.2014
This guidance document addresses a number of questions which marketing authorisation holders (MAHs) may have on post-authorisation procedures. It provides an overview of the Agency’s position on
...
GMP: Waiting for ICH Q3D (Step 4): Revision and Implementation of national Regulations delayed
10.07.2014
At the end of July 2013, the Draft Consensus Guideline \"Guideline for Elemental Impurities\" (step 2b document) was released and open for comments 6 months long. After considering all the
...
